Moreover, more than 35% of patients prescribed insulin at hospital discharge were affected by CVD (heart failure and/or ischemic heart disease), thus advocating that a careful assessment among older, frail patients should be carried out before antidiabetic treatment intensification with insulin. This evidence concerns the gene INS and heart failure.